Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation

JACC: Cardiovascular Interventions(2021)10.1016/j.jcin.2020.09.051Source: DataRank Database

Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation is a research paper published in JACC: Cardiovascular Interventions (2021). On theSindex it has a DataRank of 0. It has been cited 120 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

120 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (16 grants)Impact (FWCI 14.17)OA: bronzeTopics (41)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Kasper Korsholm ORCID,Dorte Damgaard,Jan Brink Valentin ORCID,Hans‐Christoph Diener ORCID,Alan John Camm

Live enrichment

PubMed:33413867 OpenAlex:https://openalex.org/W3119560890

Novo Nordisk UK Research Foundation

Grant: NNF17OC0024868

Novo Nordisk UK Research Foundation

Grant: NNF17OC0029510

Deutsche Forschungsgemeinschaft

Grant: unidentified

unidentified

Bayer Vital

Bristol-Myers Squibb

Pfizer

Bundesministerium für Bildung und Forschung

National Institutes of Health

Medtronic

Portola Pharmaceuticals

Deutsche Forschungsgemeinschaft

Abbott Laboratories

Boehringer Ingelheim

Daiichi-Sankyo

European Commission

Sanofi

FWCI

14.17

Citation Percentile

1.0%

Citation Trend

2021

2022

2023

2024

2025

2026

bronzeLicense: Elsevier Non-Commercial

journalhttps://www.sciencedirect.com/science/article/pii/S1936879820320100/pdf

publisherhttps://www.sciencedirect.com/science/article/pii/S1936879820320100/pdf

publisherhttps://api.elsevier.com/content/article/PII:S1936879820320100?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1936879820320100?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jcin.2020.09.051

Fields of Study

Atrial Fibrillation Management and OutcomesCardiovascular Disease and AdiposityPericarditis and Cardiac Tamponade03 medical and health sciences0302 clinical medicineAgedAnticoagulantsAtrial AppendageAtrial FibrillationHumansStrokeTreatment OutcomeVenous Thromboembolism

MeSH Terms

AgedAnticoagulantsAtrial FibrillationHumansTreatment OutcomeAtrial AppendageStrokeVenous Thromboembolism

Keywords

Atrial fibrillationLeft atrial appendage occlusionMedicineCardiologyInternal medicineAppendageOcclusionAtrial AppendageStroke (engine)WarfarinSinus rhythmAnatomyStroke PreventionMedizinAnticoagulantsVenous ThromboembolismStrokeTreatment OutcomeHumansAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being